Maze Therapeutics, Inc. · NASDAQ:MAZE
Third Rock Ventures IV, L.P. reported a 9.30% stake in Maze Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 13, 2026
Third Rock Ventures IV, L.P. reported a 9.30% stake in Maze Therapeutics, Inc., 4,473,958 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).
- Stake
- 9.30%
- Shares
- 4,473,958
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Third Rock Ventures IV, L.P. | 9.30% | 4,473,958 |
| Third Rock Ventures GP IV, L.P. | 9.30% | 4,473,958 |
| TRV GP IV, LLC | 9.30% | 4,473,958 |
| Third Rock Ventures V, L.P. | 2.00% | 950,800 |
| Third Rock Ventures GP V, L.P. | 2.00% | 950,800 |
| TRV GP V, LLC | 2.00% | 950,800 |
Source
Related
- Maze Therapeutics, Inc.
- Third Rock Ventures IV, L.P.
- Maze Therapeutics, Inc. shareholders
- Schedule 13G · Third Rock Ventures IV, L.P. · May 9, 2025
- Form 4 · Bernstein Harold · Oct 2, 2026
- Form 4 · Coloma Jason V · Oct 2, 2026
- Form 4 · Dandekar Atul · Oct 1, 2026
- Form 4 · Bernstein Harold · Sep 8, 2026
- Form 4 · Bernstein Harold · Sep 4, 2026